Successful case manager-client relationships are those that demonstrate a humanistic, personal, empathetic, and empowering approach to health care provision. This editorial discusses leadership presence as an essential skill for professional case management practice and the impact of such relationships on the client/support system experience of care. It also presents a framework for building impactful and therapeutic relationships. In addition, it offers a list of key strategies that contribute to the success of the professional case manager.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/NCM.0000000000000325 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the presence and roles of humility when experiencing situations of uncertainty.
AEM Educ Train
February 2025
Department of Medicine, Division of Pulmonary and Critical Care, Sidney Kimmel Medical College Thomas Jefferson University Philadelphia Pennsylvania USA.
Background: Uncertainty is a pervasive challenge in clinical practice. Whereas the importance of humility in navigating uncertainty has been discussed, empirical research on how humility is practiced or expressed (i.e.
View Article and Find Full Text PDFDisparities of women's authorship in Colombia: A cross-sectional analysis.
PLOS Glob Public Health
January 2025
Faculty of Medicine, Universidad de Los Andes, Bogotá, Colombia.
Accepted manuscripts published in medical journals play a crucial role within the scientific community. Over the past few decades, there has been a gradual increase in the number of women entering the medical field. However, women remain underrepresented as first and last authors in medical journals.
View Article and Find Full Text PDFNursing Culture Within Higher Education: A Snapshot.
Nurs Educ Perspect
January 2025
About the Authors Ashley Singh, PhD, DNP, RN, EBP-C, CEC, BCC, is assistant professor, Chatham University College of Nursing, Pittsburgh, Pennsylvania. Diane F. Hunker, PhD, MBA, RN, is professor, Chatham University College of Health Sciences, Department of Nursing. Miron Avidan, PhD, is assistant professor within the School of Sustainability and Environment and School of Business and Enterprise at Chatham University. For more information, contact Dr. Singh at
With little literature exploring the relationship between leadership styles within teams/departments and types of organizational culture in nursing education, we conducted an exploratory study to investigate leadership styles and culture types. An online survey using the Organizational Description Questionnaire was posted on two national nursing websites. Nearly 35 percent of participants in this pilot study (n = 43) identified their organization to be coasting, followed by high contrast (23%) and transformational (21%).
View Article and Find Full Text PDFUrine kidney injury molecule-1 predicts subclinical kidney disease among persons living with HIV initiating tenofovir disoproxil fumarate-based ART in Zambia.
Front Nephrol
January 2025
Department of Nephrology, Nephrology Vanderbilt Institute for Global Health (VIGH), Nashville, TN, United States.
Introduction: Antiretroviral therapy (ART) increases the life expectancy of persons living with HIV (PLWH), but not without potentially serious adverse effects. Tenofovir disoproxil fumarate (TDF) can cause nephrotoxicity, manifesting as acute kidney injury (AKI) that may persist after treatment discontinuation. Kidney injury biomarkers such as kidney injury molecule-1 (KIM-1), retinol-binding protein-4 (RBP-4), interleukin-18 (IL-18), and neutrophil gelatinase-associated lipocalin (NGAL) can aid early diagnosis and predict TDF-associated nephrotoxicity.
View Article and Find Full Text PDFA non-interventional biomarker study in patients with adenocarcinoma of the lung treated with nintedanib plus docetaxel following progression on chemotherapy and/or immunotherapy: LUME-BioNIS.
Transl Lung Cancer Res
December 2024
Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, UK.
Background: Anti-angiogenic agents, such as nintedanib and ramucirumab, when combined with docetaxel, are subsequent treatment options in patients with non-small cell lung cancer (NSCLC) who have failed on first-line chemotherapy or immunochemotherapy. However, to date, there are no validated predictive biomarkers for efficacy of anti-angiogenic therapies in this setting. The aim of this study was to explore whether genetic or genomic markers, alone or combined with clinical covariates, could be used to predict overall survival (OS) in patients with NSCLC who are eligible for treatment with nintedanib plus docetaxel.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!